Glycotope Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 25

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $142M

Glycotope General Information

Description

Developer of a glycobiology technology designed to address tumor-specific glycol-epitope targets. The company's technology is focused on the development of clinical and pre-clinical programs with an array of modes of action to provide an offering in the immuno-oncology and oncology space, enabling doctors to treat various types of cancer with human glycosylation.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Robert-Roessle-Strasse 10
  • 13125 Berlin
  • Germany
+49 030
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • Robert-Roessle-Strasse 10
  • 13125 Berlin
  • Germany
+49 030

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glycotope Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 03-Jul-2024 $142M Completed Clinical Trials - Phase 1
5. Secondary Transaction - Private 01-May-2023 Completed Clinical Trials - Phase 1
4. Later Stage VC 08-Oct-2015 Completed Clinical Trials - Phase 1
3. Later Stage VC 12-Mar-2014 Completed Clinical Trials - Phase 1
2. Later Stage VC 03-Nov-2007 $57.1M $57.1M Completed Clinical Trials - Phase 1
1. Early Stage VC 01-Jan-2001 Completed Startup
To view Glycotope’s complete valuation and funding history, request access »

Glycotope Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a glycobiology technology designed to address tumor-specific glycol-epitope targets. The company's technolo
Drug Discovery
Berlin, Germany
25 As of 2024

Wilmington, DE
 

Ballerup, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Glycotope Competitors (16)

One of Glycotope’s 16 competitors is Ayala Pharmaceuticals, a Corporation company based in Wilmington, DE.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ayala Pharmaceuticals Corporation Wilmington, DE
Symphogen Formerly VC-backed Ballerup, Denmark
DelSiTech Venture Capital-Backed Turku, Finland
Ability Pharma Private Equity-Backed Cerdanyola, Spain
Aura Biosciences Formerly VC-backed Boston, MA
You’re viewing 5 of 16 competitors. Get the full list »

Glycotope Patents

Glycotope Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250074999-A1 Antibodies against lypd3 Pending 16-Mar-2022
WO-2023175117-A1 Antibodies against lypd3 Inactive 16-Mar-2022
WO-2022002887-A1 Humanized antibodies against lewis y Inactive 30-Jun-2020
CA-3100745-A1 Anti-muc1 antibody Pending 18-May-2018
EP-3794041-A1 Anti-muc1 antibody Active 18-May-2018 C07K16/3092
To view Glycotope’s complete patent history, request access »

Glycotope Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Glycotope Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eckert Life Science Accelerator Accelerator/Incubator Minority
Hexal Corporation Minority
Jossa Arznei VC-Backed Company Minority
Octapharma Corporation Minority
Angel (individual) Minority
To view Glycotope’s complete investors history, request access »

Glycotope Acquisitions (1)

Glycotope’s most recent deal was a Merger/Acquisition with Orpegen Pharma. The deal was made on 24-Jul-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Orpegen Pharma 24-Jul-2008 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Glycotope’s complete acquisitions history, request access »

Glycotope Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Glycotope Biotechnology (Recombinant Technology) Heidelberg, Germany 2008

Glycotope FAQs

  • When was Glycotope founded?

    Glycotope was founded in 2000.

  • Where is Glycotope headquartered?

    Glycotope is headquartered in Berlin, Germany.

  • What is the size of Glycotope?

    Glycotope has 25 total employees.

  • What industry is Glycotope in?

    Glycotope’s primary industry is Drug Discovery.

  • Is Glycotope a private or public company?

    Glycotope is a Private company.

  • What is the current valuation of Glycotope?

    The current valuation of Glycotope is .

  • What is Glycotope’s current revenue?

    The current revenue for Glycotope is .

  • How much funding has Glycotope raised over time?

    Glycotope has raised $285M.

  • Who are Glycotope’s investors?

    Eckert Life Science Accelerator, Hexal, Jossa Arznei, Octapharma, and have invested in Glycotope.

  • Who are Glycotope’s competitors?

    Ayala Pharmaceuticals, Symphogen, DelSiTech, Ability Pharma, and Aura Biosciences are some of the 16 competitors of Glycotope.

  • When was Glycotope acquired?

    Glycotope was acquired on 03-Jul-2024.

  • Who acquired Glycotope?

    Glycotope was acquired by Pentixapharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process